weak sales
-
Financial
J&J’s Med Tech Buisness Falters Amid Weak Sales,
The calendar has finally caught up with Johnson & Johnson ($JNJ). Quarter after quarter, the healthcare giant watched its $21.3…
Read More »
The calendar has finally caught up with Johnson & Johnson ($JNJ). Quarter after quarter, the healthcare giant watched its $21.3…
Read More »